ADHERENCE TO TREAT-TO-TARGET APPROACH IN A RHEUMATOID ARTHRITIS COHORT: RETROSPECTIVE ANALYSIS FROM 3 YEARS OF REAL-LIFE EXPERIENCE IN A REFRACTORY CLINIC

被引：0
|
作者：
Maranini, B. [1 ]
Silvagni, E. [1 ]
Venturelli, V. [1 ]
Piovani, A. [2 ]
Zagnoni, E. [1 ]
Govoni, M. [1 ]
机构：
[1] Univ Ferrara, Dept Med Sci, Ferrara, Italy
[2] Univ Bologna, Dept Phys Augusto Righi, Bologna, Italy
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Treat to target; Rheumatoid arthritis; bDMARD;
D O I：
10.1136/annrheumdis-2023-eular.2829
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0223
引用
收藏
页码：1295 / 1296
页数：2
相关论文
共 50 条
  • [31] Baricitinib versus TNF-inhibitors in Patients with Active Rheumatoid Arthritis After Failure of CsDMARDs: A Pragmatic, Multicenter, Real-Life Study in a Treat-to-Target Setting
    Van de laar, Martinus
    Voshaar, Martijn Oude
    ten Klooster, Peter
    Tedjo, Danyta
    van de laar, Celine
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 872 - 874
  • [32] THE RELATIONSHIP BETWEEN ADHERENCE TO A TREAT-TO-TARGET APPROACH FOR CLINICAL CARE OF US PATIENTS WITH RHEUMATOID ARTHRITIS AND ACHIEVEMENT OF LOW DISEASE ACTIVITY
    Harrold, L. R.
    Reed, G. W.
    John, A.
    Barr, C. J.
    Saunders, K. C.
    Soe, K.
    Magner, R.
    Greenberg, J. D.
    Kremer, J. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 199 - 200
  • [33] Implementation of Treat-to-Target for Rheumatoid Arthritis in the US: Analysis of Baseline Data From a Randomized Controlled Trial
    Yu, Zhi
    Lu, Bing
    Agosti, Jenifer
    Bitton, Asaf
    Corrigan, Cassandra
    Fraenkel, Liana
    Harrold, Leslie R.
    Losina, Elena
    Katz, Jeffrey N.
    Solomon, Daniel H.
    ARTHRITIS CARE & RESEARCH, 2018, 70 (05) : 801 - 806
  • [34] EFFICACY AND RETENTION RATE OF CERTOLIZUMAB PEGOL IN RHEUMATOID ARTHRITIS: DATA FROM A LARGE REAL-LIFE MULTICENTRE RETROSPECTIVE COHORT
    Favalli, E. G.
    Becciolini, A.
    Puttini, P. Sarzi
    Atzeni, F.
    Bortolotti, R.
    Monti, S.
    Lomater, C.
    Gorla, R.
    Bazzani, C.
    Caporali, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 601 - 601
  • [35] Rituximab Retreatment in Rheumatoid Arthritis in a Real-life Cohort: Data from the CERERRA Collaboration
    Chatzidionysiou, Katerina
    Lie, Elisabeth
    Lukina, Galina
    Hetland, Merete L.
    Hauge, Ellen-Margrethe
    Pavelka, Karel
    Gabay, Cem
    Scherer, Almut
    Nordstrom, Dan
    Canhao, Helena
    Santos, Maria Jose
    Tomsic, Matija
    Rotar, Ziga
    Victoria Hernandez, M.
    Gomez-Reino, Juan
    Ancuta, Ioan
    Kvien, Tore K.
    van Vollenhoven, Ronald
    JOURNAL OF RHEUMATOLOGY, 2017, 44 (02) : 162 - 169
  • [36] Is treat-to-target really working in rheumatoid arthritis? a longitudinal analysis of a cohort of patients treated in daily practice (RA BIODAM)
    Ramiro, Sofia
    Landewe, Robert B. M.
    van der Heijde, Desiree
    Sepriano, Alexandre
    FitzGerald, Oliver
    Ostergaard, Mikkel
    Homik, Joanne
    Elkayam, Ori
    Thorne, J. Carter
    Larche, Margaret
    Ferraccioli, Gianfranco
    Backhaus, Marina
    Boire, Gilles
    Combe, Bernard
    Schaeverbeke, Thierry
    Saraux, Alain
    Dougados, Maxime
    Rossini, Maurizio
    Govoni, Marcello
    Sinigaglia, Luigi
    Cantagrel, Alain G.
    Allaart, Cornelia F.
    Barnabe, Cheryl
    Bingham, Clifton O.
    Tak, Paul P.
    van Schaardenburg, Dirkjan
    Hammer, Hilde Berner
    Dadashova, Rana
    Hutchings, Edna
    Paschke, Joel
    Maksymowych, Walter P.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (04) : 453 - 459
  • [37] OUTCOMES OF DISEASE ACTIVITY IN A 5-YEAR LARGE COHORT OF RHEUMATOID ARTHRITIS PATIENTS TREATED UNDER TREAT TO TARGET RECOMMENDATIONS AND A MULTIDISCIPLINARY CARE MODEL - A REAL-LIFE EXPERIENCE
    Santos-Moreno, P.
    Gomez, D.
    Castillo, E.
    Giraldo, R.
    Ballesteros, G.
    Villarreal, L.
    Bello, J.
    Buitrago-Garcia, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 529 - 529
  • [38] PERFECTRA: a pragmatic, multicentre, real-life study comparing treat-to-target strategies with baricitinib versus TNF inhibitors in patients with active rheumatoid arthritis after failure on csDMARDs
    van de Laar, Celine J.
    Voshaar, Martijn A. H. Oude
    ten Klooster, Peter
    Tedjo, Danyta, I
    Bos, Reinhard
    Jansen, Tim
    Willemze, A.
    Versteeg, Grada A.
    Goekoop-Ruiterman, Y. P. M.
    Kroot, Eric-Jan
    van de Laar, Mart
    RMD OPEN, 2024, 10 (02):
  • [39] Bimekizumab in Biologics-Refractory Psoriatic Arthritis: A Real-Life Analysis from a Combined Dermatology-Rheumatology Clinic
    Zabotti, Alen
    Cabas, Nicola
    Giovannini, Ivan
    Guella, Silvia
    Cereser, Lorenzo
    Zuiani, Chiara
    Stinco, Giuseppe
    Quartuccio, Luca
    Errichetti, Enzo
    CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2024, 17 : 1553 - 1556
  • [40] TWO YEARS OF REAL-LIFE EXPERIENCE WITH USTEKINUMAB IN A SPANISH COHORT OF REFRACTORY ULCERATIVE COLITIS PATIENTS.
    Iborra, Marisa
    Ferreiro, Rocio
    Martin-Arranz, Md
    Mesonero, Francisco
    Minguez, Alejandro
    Porto-Silva, Sol
    Garcia-Ramirez, Laura
    de la Filia, Irene Garcia
    Aguas, Mariam
    Nieto-Garcia, Laura
    Ferrer, Cristina Suarez
    Bastida, Guillermo
    Barreiro-De-Acosta, Manuel
    Nos, Pilar
    GASTROENTEROLOGY, 2023, 164 (06) : S1130 - S1130
12345